| Biosimilar development | ||
| 03-06-23 Hit 609 | ||
Biosimilars are formulated to have similar ingredients and efficacy according to the patent expiration of bionews (protein drugs). Compared to cloned protein drugs and bionew drugs, the efficacy is similar but economical due to low price. As it is recognized as a medicine, we will learn the necessity of leading biotechnology development of domestic companies and the process that can be pursued by bio-new drug development after long-term technology accumulation.